Blog - Page 679 of 5690 - QualityStocks

WednesdayJul 19, 2023 1:52 pm

QualityStocksNewsBreaks – CISO Global Inc. (NASDAQ: CISO) Announces Strategic Acquisition of SB Cyber Technologies LLC

CISO Global Inc. (NASDAQ: CISO), an industry leader as a managed cybersecurity and compliance provider, today announced that it has acquired SB Cyber Technologies, a cybersecurity company that specializes in identifying, enhancing and applying emerging government and military grade capabilities to critical commercial technical security challenges. Under the agreement, SC Cyber has become a wholly owned subsidiary of CISO Global. Based in Chesapeake, Virginia, and founded by former members of the U.S. intelligence and special operations communities, SB Cyber developed CHECKLIGHT(R), a powerful and proactive endpoint detection and response (“EDR”) technology that detects potential threats to endpoints, such as laptops…

WednesdayJul 19, 2023 1:40 pm

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces $7.5M Registered Direct Offering

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced its entry into definitive agreements with health care-focused institutional investors. The agreements are for the sale and issuance of 7,425,744 shares of the company’s common stock and warrants to purchase up to 7,425,744 shares of common stock at a combined offering price of $1.01 per share of common stock and accompanying warrant, in a registered direct offering priced at-the-market under the Nasdaq rules. The warrants have an exercise price of $0.885 per share, exercisable at the date of issuance…

WednesdayJul 19, 2023 12:27 pm

QualityStocksNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Continues Sales Momentum with Announcement of Three New Orders

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has received three new sales, for a total of eight new units. The sales, which came from a military base, a mall and a university, come on the heels of a consistent stream of orders the company has received. According to the announcement, the Nellis Air Force Base is expanding the use of K1 Retrofit Kits through a Knightscope reseller; the base has 20 competitor products that have been retrofitted with Knightscope’s modern technologies. The result is extremely cost-effective systems that utilize cellular…

WednesdayJul 19, 2023 11:55 am

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Portfolio in Oral Nicotine Delivery Sector

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that it was granted a strategically important new patent in the oral nicotine sector by the United States Patent and Trademark Office (“USPTO”). According to the update, U.S. patent #11,700,875 Compositions and Methods For Sublingual Delivery of Nicotine includes claims for many types of nicotine, including nicotine benzoate, nicotine ditartrate, nicotine citrate, nicotine polacrilex, and many others, for use in sublingual delivery formats like oral pouches. The company’s superior DehydraTECH processing and sublingual compositions have now been recognized through exceptional scientific study results as well as…

WednesdayJul 19, 2023 10:30 am

Data443 Risk Mitigation Inc. (ATDS) Employs Cyber Threat Intelligence Solutions as it Helps Businesses Stay Ahead of Cyber Criminals

Businesses around the world are expected to face as many as 33 billion data breaches throughout 2023 Increasingly, businesses are finding that firewalls and antivirus software are unable to keep hackers at bay Cyber Threat Intelligence (“CTI”), a data collection tactic that allows companies to better assess the potential threats they face, has become an increasingly valuable tool in helping businesses address their vulnerabilities Data443 Risk Mitigation’s CTI-enabled product suite has been designed to provide businesses with an array of tools designed to help safeguard their data Cyber-attacks have become an increasingly ubiquitous facet of modern business; in 2023 alone,…

WednesdayJul 19, 2023 9:45 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) CEO Amir Reichman Featured on IBN’s The Bell2Bell Podcast

Reichman discusses BiondVax’s 2023 achievements, including the development of innovative NanoAbs in collaboration with the Max Planck Institute targeting interleukin-17 (IL-17) targeting diseases such as psoriasis Annual sales for current anti-interleukin-17 monoclonal antibodies now total about $7.5 billion annually – and BiondVax is positioned to penetrate this market with promising results Investor Brand Network (“IBN”) recently announced the release of its latest episode of The Bell2Bell Podcast, featuring Amir Reichman, CEO of BiondVax Pharmaceuticals (NASDAQ: BVXV). The Bell2Bell Podcast delivers informative updates and exclusive interviews with executives operating in fast-moving industries – like BiondVax’s innovative platform technology using alpaca-derived nanosized…

WednesdayJul 19, 2023 9:00 am

Fintech Ecosystem Development Corp. (NASDAQ: FEXD) Looking to Empower Populations As Fintech Shifts Consumer and Businesses Purchasing Power

FEXD, a company formed to develop a global financial technology ecosystem, continues to develop a diverse portfolio of FinTech-related products and services to consumers and businesses in the United States, South Asia, East Asia, Africa, Europe, and Latin America The goal is to empower underserved populations by providing FinTech solutions that boost and shift purchasing power Fintech innovations affect various dimensions of financial services, including domestic payments, credit, remittances, savings, insurance, and investment management Access to credit and remittances have been shown to have positive effects on purchasing power On its part, FEXD aims to develop products that help consumers…

TuesdayJul 18, 2023 2:49 pm

QualityStocksNewsBreaks – Bollinger Motors, a Majority-Owned EV Truck Company of Mullen Automotive Inc. (NASDAQ: MULN), Kicks off ‘Design Validation’ Pilot Builds

Bollinger Motors, which in September of 2022 became a majority-owned EV truck company of Mullen Automotive (NASDAQ: MULN), today announced the start of its “design validation” pilot builds of the B4 all-electric Class 4 chassis cabs for testing and demonstration. According to the announcement, manufacturing of the pilot vehicles has kicked off in partnership with Roush Industries Inc. at its facility in Livonia, Michigan. The first five completed chassis cabs are expected to roll out this summer, with another 15+ vehicles by the end of the third quarter of 2023. “Bollinger Motors has over eight years of experience in developing,…

TuesdayJul 18, 2023 2:00 pm

QualityStocksNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Completes Game-Changing Integration with Samsara

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a tech company on a mission to revolutionize cross-border shipping by offering carriers increased growth opportunities and shippers with flexibility, visibility and simplicity, recently announced its new integration with Samsara, a pioneer of the Connected Operations(TM) Cloud. “Samsara’s Connected Operations Cloud has helped differentiate the company in its segment by making it easy for organizations to access, analyze and act upon real-time data from tracks, trailers, warehouses, and equipment. In turn, users have enjoyed improved safety, efficiency, and sustainability, allowing for better and even more profitable operations. With the integration, Fr8App customers can now view…

TuesdayJul 18, 2023 1:36 pm

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Enters Exclusive License Agreement with University of Pittsburgh

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, has signed an exclusive license agreement with the University of Pittsburgh. The agreement grants Genprex worldwide, exclusive rights to a patent application and related technology for a gene therapy targeting both type 1 and type 2 diabetes. The therapy utilizes Pdx1 (“Pdx1”) and MafA (“MafA”) genes controlled by an MafB (“MafB”) promoter and administered through an adeno-associated virus (“AAV”) vector directly into the pancreatic duct. Preclinical data from nonhuman primate models of type 1 diabetes show promising results, with significant decreases…

Site Search

Company Search